Concurrent opioid and alcohol withdrawal management-Reference-Cited by-同舟云学术

Concurrent opioid and alcohol withdrawal management

Published:2023-12-01 Issue:6 Volume:13 Page:268-275
ISSN:2168-9709
Container-title:Mental Health Clinician
language:en
Short-container-title:

Author:

Colvard Michelle^ORCID

Abstract

Abstract Concurrent alcohol and opioid withdrawal syndrome is a common and challenging clinical scenario with little published evidence or guidance to inform pharmacotherapy strategies. Concurrent use of benzodiazepines and opioid agonists, which are considered first-line agents for management of each withdrawal syndrome independently, is controversial and often avoided in clinical practice. Strategies to provide effective, simultaneous medication treatment of alcohol and opioid withdrawal while optimizing patient safety are demonstrated through 3 patient cases.

Publisher

College of Psychiatric and Neurologic Pharmacists (CPNP)

Subject

Pharmacology (medical),Neurology (clinical),General Pharmacology, Toxicology and Pharmaceutics,Neuropsychology and Physiological Psychology

Link

https://meridian.allenpress.com/mhc/article-pdf/13/6/268/3296160/i2168-9709-13-6-268.pdf

Reference49 articles.

1. Center for Substance Abuse Treatment detoxification and substance abuse treatment. Treatment Improvement Protocol (TIP) Series, No. 45. HHS Publication No.(SMA) 15-4131. Center for Substance Abuse Treatment, 2006 .

2. American Society of Addiction Medicine clinical practice guideline on alcohol withdrawal management,2020

3. American Society of Addiction Medicine national practice guideline for the treatment of opioid use disorder,2020

4. Treatment of patients with substance use disorders, second edition. American Psychiatric Association;Kleber;Am J Psychiatry,2007

5. VA/DoD clinical practice guideline for the management of substance use disorders,2021